CorMedix Announces CMS Grants Pass-Through Status For DefenCath Under Hospital Outpatient Prospective Payment System (OPPS)
Portfolio Pulse from Benzinga Newsdesk
CorMedix announced that the Centers for Medicare & Medicaid Services (CMS) has granted pass-through status for DefenCath under the Hospital Outpatient Prospective Payment System (OPPS).
June 06, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CorMedix's DefenCath has been granted pass-through status by CMS under the OPPS, which could enhance its market adoption and revenue potential.
The pass-through status from CMS allows for separate payment for DefenCath, which can lead to increased adoption in hospitals and higher revenue for CorMedix.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100